|
|
 |
|
Viewing report
|
|
|
|
Achillion Pharmaceuticals, Inc.
Datamonitor, Sep 2008, Pages: 22
The Achillion Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Achillion Pharmaceuticals (Achillion) is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of human immunodeficiency virus (HIV) infection, chronic hepatitis C and serious hospital-based bacterial infections. Achillion is headquartered in New Haven, Connecticut and had 60 full time employees as of March 2008. The company recorded revenues of $4 million during the financial year (FY) ended December 2007, an increase of 22.6% over FY2006. The increase was primarily attributable to higher revenues from the collaboration agreement with Gilead Sciences for development of ACH-1095 and NS4A antagonists. The operating loss of the company was $31 million during FY2007, as compared to an operating loss of $24 million in FY2006. The net loss was $28 million in FY2007, as compared to a net loss of $24 million in FY2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Premium Company Profile Achillion Pharmaceuticals
Achillion Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Amylin Pharmaceuticals, Inc. - SWOT Analysis
Idenix Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. - SWOT Analysis
Progenics Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. - SWOT Analysis
Cubist Pharmaceuticals, Inc. - SWOT Analysis
Isis Pharmaceuticals, Inc. - SWOT Analysis
ISTA Pharmaceuticals, Inc. - SWOT Analysis
Auxilium Pharmaceuticals, Inc.
|
|
|
|
